To investigate the pathogenesis of human T cell lymphotropic virus type I (HTLV-I)-associated chronic inflammatory arthropathy (HAAP), we sought to detect proviral DNA in the articular lesions. For the detection of proviral DNA, we used the polymerase chain reaction (PCR). Proviral DNA was detected not only in the peripheral blood mononuclear cells (PBMCs) and synovial fluid cells (SFCs), but also in the T lymphocyte-depleted cultured synovial cells (CSCs). These findings suggest that the infection by HTLV-I might occur in vivo in non-T cells. Furthermore, we detected HTLV-I tax,/ rex, messenger RNA in fresh synovial tissues and CSCs but not in fresh PBMCs and fresh SFCs using reverse transcription and PCR. Immunohistochemically, the CSCs from HAAP patients were also shown to express the HTLV-I antigens. These data indicate that HTLV-I in the non-T synovial cells can be transcribed and expressed. Moreover, the sequences of pXII regions in the CSCs demonstrated 97.5-99.4% homology to that in MT-2 cells, HTLV-I-infected cell line. This confirmed that the PCR-amplified bands reflect HTLV-I itself. These results suggest that this organ-specific inflammation can be attributed to non-T cell virus infection in articular lesions. (J. Clin.
Introduction
Human T cell lymphotropic virus type I (HTLV-I)1 is known as an etiologic agent of adult T cell leukemia (ATL) (1) . In this disease a monoclonal genomic integration of proviral HTLV-I 1. Abbreviations used in this paper: ATL, adult T cell leukemia; CSC, cultured synovial cell; FST, fresh synovial tissue; HAAP, HTLV-I-associated arthropathy; HAM/TSP, HTLV-I-associated myelopathy/ tropical spastic paraparesis; HTLV-I, human T cell lymphotropic virus type I; PCR, polymerase chain reaction; RA, rheumatoid arthritis; RT, reverse transcription; SFC,~y novial fluid cell.
DNA has been demonstrated (2) . Recent studies have also revealed an association between HTLV-I and a subset ofchronic progressive myelopathy, called HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP) (3, 4) . A random integration of HTLV-I proviral DNA has been reported in peripheral blood mononuclear cells (PBMCs) and the cells isolated from cerebrospinal fluid from patients with HAM (5) . Although the role of HTLV-I infection in HAM/TSP disorders has not yet been clarified, HTLV-I is thought to be involved in the pathogenesis of such neurological disorders.
Recently, other organ systems besides the nervous system have been reported to be involved in HAM/TSP. Manifestations of their involvement include alveolitis (6) , Sjogren syndrome (7) , and polymyositis (8) . We have also previously reported a case ofproliferative synovitis in a patient with chronic ATL (9) and cases of polyarthritis in patients with HAM (10) . Furthermore, a chronic inflammatory arthropathy was found to occur in HTLV-I carriers and we have thus likened it to HTLV-I-associated arthropathy (HAAP) (1 1). However, the pathological association of this arthropathy with the virus remains to be clarified.
To approach this problem, we have attempted to detect HTLV-I proviral DNA in the tissue of this inflammatory arthropathy. We report here that the proviral DNA could be detected not only in T cells but also in non-T cells in the synovium of patients with HAAP. Moreover, viral gene expression was also detected both in the fresh synovial tissues (FSTs) and in T cell-depleted cultured synovial cells (CSCs) . Finally, we have confirmed that the virus is HTLV-I by demonstrating HTLV-I pXII DNA sequences in the CSCs of the HAAP patients.
Methods
Patients. Two patients with chronic persistent oligo-arthritis in relatively large joints associated with proliferative synovitis were studied. They had anti-HTLV-I antibodies in serum and synovial fluid (SF) as assessed by the particle agglutinin method (ATLA kit, Serodia, Fujirebio, Inc., Tokyo, Japan) (12) and confirmed by Western blot analysis (13) . Their clinical profiles were consistent with HAAP (1 1). Two patients with rheumatoid arthritis (RA) with negative anti-HTLV-I antibodies were also studied. (14) . To obtain nonlymphoid cells from synovial tissues, cells were cultured for short periods. The biopsied synovial tissues were minced into small pieces and cultured for 12 d in RPMI-1640 (Gibco Laboratories, Grand Island, NY) with 10% fetal calf serum (Gibco Laboratories), 100 U/ml of penicillin, 100 Mg/ml of streptomycin, and 10 mM of Hepes (Sigma Chemical Co., St. Louis, MO). Culture medium were changed every 3 d, and nonadherent lymphoid cells were removed. Adherent synovial cells were maintained in the culture for 12 d. Contamination by CD2-positive (a pan-T cell marker) cells in these adherent cell populations, estimated by immunostaining and then determined by counting, was less than 1 in 10,000 of the CSCs (data not shown). MT-2 cells, a human HTLV-I-infected T cell line, were reported often to contain a number ofproviral DNA copies in long-term culture conditions (15) . We used MT-2 cells from frozen conditions and cultured for short durations that were confirmed to contain one or two copies of the viral genome in one cell by an EcoRI digesting study (data not shown). These MT-2 cells and PBMCs from an ATL patient were used as positive controls for virus detection and gene expression.
DNA and RNA preparation. Chromosomal DNA was isolated by SDS/proteinase K/RNase A digestion of cells, followed by phenol and chloroform extraction (16) , whereas cytoplasmic RNA was isolated by the acid guanidinium thiocyanate-phenol-chloroform extraction method (17) . The DNA and RNA concentrations were estimated by measuring the absorbance ratio at 260/280 nm.
Detection ofthe HTL V-I proviral DNA. Polymerase chain reaction (PCR), a procedure for an enzymatic amplification of DNA, was used for detection of the proviral DNA (18) . Oligonucleotide primers for PCR were synthesized on a DNA synthesizer (model 380A, Applied Biosystems, Inc., Foster City, CA). The primers used in this study are summarized in Table I . Amplified DNAs included HTLV-I gag (product size: 535 base pairs [bp] [19] ), env (327 bp) (19) , pX (159 bp) (20) , and as an internal control, HLA DQB (238 bp) (21) . The PCR reaction mixtures (100 Ml) included 1 Mg of DNA sample, 100 pmol of each primer, 400 Mmol of each deoxynucleotide triphosphate, and 2.5 U of the heat-stable DNA polymerase (Taq) (Perkin-Elmer Cetus, Norwalk, CT) (22) . The amplification procedure consisted of 35 cycles of the following steps: (a) 94°C for 1 min for denaturation, (b) 60°C for 2 min for annealing, and (c) 72°C for 3 min for extension. One tenth of the resultant amplified DNA was then separated in 4% Nusieve (FMC BioProducts, Rockland, ME) agarose gel electrophoresis and visualized with ethidium bromide fluorostaining. In other experiments, DNAs in agarose gels were blotted on a nylon membrane according to the method of Southern (23) . The blotted filters were prehybridized for 12 h at 42°C and then hybridized for 15 h at 42°C with a digoxigenin-11-dUTP-labeled genomic HTLV-I probe (24) . Detection using the digoxigenin-labeled probe was performed with an anti-digoxigenin antibody conjugated with alkaline phosphatase. This was visualized using an enzyme-linked color reaction (Boehringer-Mannheim Corp., Mannheim, FRG).
Detection ofHTL V-I tax,/rex, messenger RNA (mRNA) by reverse transcription (RT) and PCR (RT-PCR). For detection of HTLV-I mRNA, RT-PCR was carried out by the method of Kinoshita et al. (25) . Briefly, 1 Mg oftotal cytoplasmic RNA was annealed with 200 ng ofrandom hexadeoxynucleotide primers in a total volume of20 Ml and was reverse-transcribed with 50 U of avian leukemia virus (ALV) reverse transcriptase at 42°C for 1.5 h. The primers (RPX3 and RPX4) (20) for the PCR amplification (Table I) DNA sequencing of pXII regions of CSCs from HAAP patients. DNAs of CSCs from each HAAP patient and MT-2 cells were amplified with PCR using SK43 and SK44 HTLV-I pXII primers (20) (Table  I) . Amplified DNAs was subcloned into the pUC 18 vector. The DNA sequence was determined by the dideoxynucleotide method and fluorescence-based automated DNA sequencing (automated DNA sequencing system, model 373A, Applied Biosystems, Inc.) (26). The nucleotide sequences from the CSCs in this study were compared with (Fig. 1 A, lanes 10, 11, 13 , and 14, respectively); only the HLA DQi3 band was observed in DNAs from the RA patients. This result was also confirmed by Southern blot analysis of the amplified DNAs using digoxigenin-labeled HTLV-I probe (Fig. 1 B) .
Next, we examined T cell-depleted CSCs. The amount of amplified proviral DNA in these specimens was estimated to be about one-fifth of that from MT-2 cells, comparing the intensity of the signals in the Southern blot analysis (Fig. 1 B, lanes  12 and 15) . 1 and 1 X 107 of HTLV-I-negative cells) only yielded very little signal in PCR followed by the Southern blot ( Fig. 1 B, lane 3) . However, the signals obtained from the CSC DNA, in which contaminating T cells were removed to be to a frequency of less than 1 in 10,000 cells, were equal to those from the PBMC and SFC DNA, which contained rich T cells. On the contrary, HTLV-I DNA was not found in the amplified DNA of the control RA patients (Fig. 1, A and B, lanes 4-9) . These results, therefore, indicated that HTLV-I proviral DNA exists in non-T cell CSCs from HAAP patients.
Detection ofHTL V-I tax,/rex, mRNA by using RT-PCR.
We attempted to detect HTLV-I tax, /rex, mRNA in articular tissues ofaffected patients. Complementary DNA (cDNA) synthesized by reverse transcriptase from RNA from articular tissues was amplified with the RPX3 and RPX4 primers located upstream and downstream from the splicing site. Therefore, in this system, contaminating DNA in these RNA samples could not contribute to the amplified products. Fig. 2 A shows the ethidium bromide fluorostaining. Bands of specific tax, /rex, mRNA (product size 154 bp) and #l-actin (218 bp) were observed in MT-2 cells. These were also confirmed by Southern blot analysis using a digoxigenin-labeled HTLV-I probe (RPXPR1) surrounding the second splice junction site of mRNA for the tax,/rex, gene (Fig. 2 B) . To determine the sensitivity of this RT-PCR, RNA from MTZ2 cells diluted serially with RNA from PBMCs of a healthy individual was tested (Fig. 2, A The signal representing the tax, /rex, mRNA was detected in both FSTs (lanes 5 and 9) and CSCs (lanes 6 and 10), but could not be detected in fresh PBMCs (lanes 7 and 11) and fresh SFCs (lanes 8 and 12) from two HAAP patients by gel electrophoresis and Southern blot analysis. In the same studies of FSTs, CSCs, fresh PBMCs, and fresh SFCs from RA patients, only f3-actin signal was detected (lanes [13] [14] [15] [16] . From the intensities of the bands, the amount oftax, /rex, mRNA in the FSTs and the CSCs from HAAP patients (lanes 5, 6, 9, and 10) was equal to that of 1 X 10-4 diluted MT-2 RNA with HTLV-I-negative RNA (lane 2). From these studies, it was found tax1 / rex1 mRNA could be expressed in articular lesions as well as CSCs in patients with HAAP, but these signals were not detected in fresh circulated PBMCs and fresh SFCs in these patients.
To confirm further the expression of HTLV-I mRNA in non-T synovial cells, another RT-PCR to co-amplify a message specific for T cells was performed. In FCTs from HAAP patients, the amplified signals of the constant region of T cell receptor (TCR) a chain were almost the same amount ofthose of HTLV-I tax I/rex1. On the contrary, in CSCs from HAAP patients, the signals of TCR were hardly observed, but those of HTLV-I tax1 /rexI were almost the same intensities as in FSTs (data not shown).
Immunostaining for the HTL V-I antigens. We next performed immunostaining to assess the expression of viral antigen in CSCs of HAAP patients. These cells did not react with anti-CD2 or anti-CD20 antibody. A part of the CSCs stained with anti-CD 14 antibody, indicating they were macrophages. Most ofthe CSCs, which were morphologically similar to fibroblasts, were found to be strongly reacted with monoclonal antibodies against the HTLV-I core protein (gag, p19 and p28) (Fig. 3 a, GIN 14) and against the other HTLV-I core protein (gag, p24) (Fig. 3 b, NOR 1) as well as to be reacted moderately with a monoclonal antibody against the HTLV-I envelope glycoprotein (env) (Fig. 3 c, FlO) . On the other hand, CSCs from RA patients could not be reacted with these HTLV-I monoclonal antibodies (data not shown). These suggest that the fibroblast-like nonlymphoid CSCs in patients with HAAP patients express HTLV-I viral antigens.
DNA sequence of the pXII region of HTL V-I in CSCs of HAAP patients. Since the amplified DNA in the CSCs from HAAP patients hybridized with HTLV-I probes, these DNAs were likely to be HTLV-I. The DNA sequences were further analyzed to confirm this. The sequences of the pXII region in the CSCs from HAAP patients were determined by the dideoxynucleotide method. The sequences as well as those ofreported HTLV family are shown in Fig. 4 . The homology of the sequences derived from CSCs of HAAP patient 1 (CSCl) and patient 2 (CSC2) was 98.6%. The sequence of this region of DNA derived from MT-2 cells examined in this study was the same as that derived from ATK-I (27) . The homologies between the sequences generated from CSCI, CSC2 and MT-2 cells, or ATK-I were 97.5% and 99.4%, respectively. Those between CSC1, and CSC2 and HTLV-II were 83.0% and 84.2%, and these between CSC1, and CSC2 and STLV were 90.6% and 92.4%. The sequence homologies among various clones of HTLV-I in the pXII region were reported to range from 97% to 99% (27, 30) . The complete DNA sequence of a cloned provirus of HTLV-II (28) is 60% homology with HTLV-I. The sequence homology of STLV (29) with HTLV-I is 90-95%.
Therefore the DNA sequences generated from the CSCs of HAAP patients can be variations of HTLV-I itself.
Discussion
To assess the relationship of HTLV-I infection and inflammatory arthropathies seen in HTLV-I-infected individuals, we examined affected synovial tissues for the presence of proviral DNA. We found HTLV-I proviral DNA in PBMCs and SFCs as well as T cell-depleted CSCs from two patients with HAAP. Furthermore, the viral gene expression in FSTs and CSCs from articular lesions was also detected. In contrast, the viral gene To estimate the amount ofproviral DNA, we compared the amplified proviral DNA to the amplified single-copy human gene, HLA DQB (36) . A titration analysis was also performed with MT-2 DNA mixed with HTLV-I-negative DNA. The amount of amplified proviral DNA in CSCs as well as PBMCs and SFCs was estimated to be about one-fifth of that of MT-2 cells by comparing the intensity of signals in the Southern blot analysis. It is impossible to obtain this amount ofamplification from a small percentage of contaminated T cells in CSCs. The possibility of the contamination from exogenous DNA was also carefully excluded. DNA from patients was extracted separately from MT-2 cells on different days. Our DNA sequence study also suggests that the contamination by the MT-2 DNA cells could not contribute to the amplification. Moreover, HTLV-I sequences could not be amplified from DNAs of PBMCs, SFCs, and CSCs from two RA patients in the experiments performed at the same time. Thus, these data suggest that the HTLV-I DNA detected in this study represent the proviral DNA in the articular tissue of patients with HAAP.
It is, however, still possible that the detected HTLV-I proviral DNA in non-T cell CSCs could be due to in vitro transmission from contaminating HTLV-I-infected T cells during the short culture periods. To exclude this possibility, we preliminarily co-cultured CSCs from RA patients mixed with MT-2 cells (CSCs/MT-2 cells = 5 X 10-4/ml/5 x 104/ml) for 12 d.
These CSCs co-cultured with MT-2 cells were then examined by immunostaining analysis using the anti-HTLV-I monoclonal antibodies (GIN 14, NOR 1, and F1O). However, no synovial cells were reacted to such HTLV-I monoclonal antibodies (data not shown). HTLV-I transmissibility is generally low in vitro. This transfer occurs only after long cell-to-cell co-culture of HTLV-I-producing cells with target cells (37). It is, therefore, unlikely that in vitro transmission to non-T cells in culture contributed to the amplified products obtained from CSC DNA and to the positive immunostaining with anti-HTLV-I monoclonal antibodies.
In our study, HTLV-I tax1/rex, mRNA could-be detected in FSTs from articular lesions but not in circulating fresh PBMCs and fresh SFCs of HAAP patients. This is the first demonstra-tion that HTLV-I viral expression level can be higher in the synovial lesions than in circulating fresh PBMCs in HTLV-I carriers. We previously reported that both IgM and IgG anti-HTLV-I antibodies persist in the synovial fluid ofthe articular lesions but not in the sera in patients with this arthropathy (10) . It has, therefore, been suggested that HTLV-I antigens might be continuously expressed in the articular lesions.
It is worth mentioning that an association between retrovirus infection and arthropathy with synovial hyperplasia has been described in lentiviral infections of sheep and goats (38) . However, retrovirus-induced arthritis in humans is now controversial. An arthritis associated with human immunodeficiency virus (HIV) infection has been recognized as a new clinical entity (39) , whereas Sokoloff reported this arthritis to be a nonspecific opportunistic infectious arthritis (40) . Nevertheless, there are interesting implications for our study that Bentin et al. (41) reported that HIV-like particles could be found electron-microscopically among synoviocyte cell fragments from HIV-infected patients.
Immunohistochemical localization of HTLV-I-related antigens has been reported in the synovial tissues in RA patients (42) . In these reports, the susceptibility to infection ofarticular tissues may indicate a role for retrovirus in the etiopathogenesis of inflammatory arthropathy.
In the present study, HTLV-I proviral DNA was detected in the SFCs from the articular lesions of HAAP patients. These HTLV-I-infected lymphocytes in the articular lesions might directly induce the inflammatory arthropathy. Preliminary phenotypic analysis of lymphocytes from the synovial tissues and SFCs by flow cytometry revealed a predominance of activated T cells of both CD4-and CD8-positive populations. Salahuddin et al. (43) have reported that T cells infected with HTLV-I produced multiple cytokines, and Wano et al. (44) have demonstrated that the interleukin 1 (IL-1) gene is expressed in ATL cells. We have also shown that ATL cells in the synovial tissues constitutively produce IL-l-like factors, which promote the growth of synovial cells (9) . Moreover, our preliminary experiments have demonstrated the presence of IL-1 and IL-6 activity in the culture supernatants of SFCs from HAAP patients (data not shown). These findings show the synovial lymphocytes infected with HTLV-I may be an important factor in this pathogenesis of inflammatory arthropathy in HTLV-I-infected individuals.
The pX sequence of HTLV-I encodes the tax, and rex1. In the present study, tax1/rex1 mRNA could be detected in non-T cell population isolated from the articular tissue of patients with HAAP. Tax1 encodes p401, which has been shown to activate not only the HTLV-I gene but also a variety ofcellular genes in trans, including IL-2, the IL-2 receptor, IL-3, IL4, and lymphocyte/macrophage colony-stimulating factor (45) (46) (47) 
